Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. (Q47930591)

6 February 2018

title

Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. (English)

1 reference

6 February 2018

1 reference

Asanuma M

1

1 reference

6 February 2018

Hirata H

series ordinal

2

1 reference

6 February 2018

Cadet JL

series ordinal

3

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

6 February 2018

published in

Neuroscience

1 reference

6 February 2018

volume

85

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

907-917

1 reference

6 February 2018

Oxygen free radicals and Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Brain Peroxidase and Catalase in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Free radicals and the pathobiology of brain dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Pergolide can induce soluble superoxide dismutase in rat striata

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Methamphetamine-induced neuronal damage: a possible role for free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

6-Hydroxydopamine: Evidence for Superoxide Radical as an Oxidative Intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Glutathione peroxidase activity in Parkinson's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Changes in lipid peroxidation, Cu/Zn-superoxide dismutase and its mRNA following an intracerebroventricular injection of 6-hydroxydopamine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P-450 reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900665-9

7 January 2021

10.1016/S0306-4522(97)00665-9

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9639283

1 reference

6 February 2018